Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Controlled Release"
DOI: 10.1016/j.jconrel.2018.12.048
Abstract: Abstract Glioblastoma multiforme (GBM) has few clinically approved therapeutic regimens. One of these therapeutic options includes placing biodegradable wafers releasing BCNU (Gliadel®) into the tumor bed at the time of surgical removal of the tumor.… read more here.
Keywords: wafers releasing; wafer; median survival; drug ... See more keywords